FeLV and feline cancer: reported mechanisms and open questions
Veterinary sciences · 2022
In plain language
This review reports conflicting findings on the detection of FeLV DNA integrated into cells in lymphomas from cats with negative antigen tests. Finding that DNA does not, on its own, show that FeLV caused an individual cat’s lymphoma. The review also describes sites where the virus frequently integrates into DNA in FeLV-associated lymphomas. The contribution of regressive infection, the possible protective role of endogenous FeLV, and how certain regions of the virus influence mutations remain unclear.
Scientific detail
The review “Infectious Causes of Neoplasia in the Domestic Cat.”, published in Veterinary sciences in 2022, addresses FeLV-associated lymphoma, leukaemia, and other neoplasms, distinguishing oncogene transduction from insertion-associated oncogenesis. The source object classifies its scope as multispecies and reports no sample size. The two selected claims about findings in the literature are assigned evidence level C; those concerning enFeLV and LTRs are presented as open questions with no assigned evidence level.
Section 2.1 reports discordant findings on provirus detection in lymphomas from antigen-negative cats. It describes disagreement between studies, not a pooled prevalence estimate. Provirus detection alone does not establish that FeLV caused an individual lymphoma, and these findings do not resolve the contribution of latent or regressive infection to lymphomagenesis.
The review identifies c-myc, flvi-1, flvi-2, fit-1, pim-1, and flit-1 as common integration loci associated with FeLV-associated lymphoma. These recurrent loci are relevant to insertion-associated oncogenesis, but their identification does not establish that they are present in every FeLV-associated lymphoma or that each integration is independently sufficient for malignant transformation.
Section 5 states that the potential protective role of enFeLV in oncogenesis and the mechanisms by which FeLV LTRs influence mutagenesis remain incompletely understood. It does not establish that endogenous FeLV prevents lymphoma. Uncertainty about LTRs does not negate the review’s conclusion that FeLV can directly induce neoplastic transformation. The supplied text does not provide sufficient primary-study methods to independently establish experimental controls or replication for the selected mechanistic claims.
What we know
The review describes discordant findings on provirus detection in lymphomas from antigen-negative cats and identifies c-myc, flvi-1, flvi-2, fit-1, pim-1, and flit-1 as common integration loci associated with FeLV-associated lymphoma. Both claims are assigned evidence level C. Provirus detection alone does not demonstrate causation in an individual case; nor is it established that these integrations occur in every case or that each is sufficient for malignant transformation. The review concludes that FeLV can directly induce neoplastic transformation.
What we don't know
The discordant findings do not resolve the contribution of latent or regressive infection to lymphomagenesis or provide a pooled prevalence estimate. The potential protective role of enFeLV and the mechanisms by which FeLV LTRs influence mutagenesis remain incompletely understood. It has not been established that enFeLV prevents lymphoma. The supplied text does not allow independent establishment of experimental controls or replication for the selected mechanistic claims.
Evidence
EvidenceLevel C — Preliminary evidenceConfidence 100/100
The review reports discordant findings on provirus detection in lymphomas from antigen-negative cats.
Excerpt verified in the source — verbatim, in the source's own language“However, when investigators have looked for provirus to investigate the outcomes in regressive FeLV infection, there are discordant results; some have suggested this is rare [ 72 , 73 , 74 ], whilst others have suggested as many as 20-60% of lymphomas from antigen-negative cats are provirus positive [ 75 , 76 , 77 ].”
Section 2.1 describes disagreement between studies rather than a pooled prevalence estimate. Provirus detection alone does not establish that FeLV caused an individual lymphoma, and these findings do not resolve the contribution of regressive infection.
EvidenceLevel C — Preliminary evidenceConfidence 100/100
The review identifies c-myc, flvi-1, flvi-2, fit-1, pim-1, and flit-1 as common integration loci associated with FeLV-associated lymphoma.
Excerpt verified in the source — verbatim, in the source's own language“To date, common integration sites (CISs) for the development of FeLV-associated lymphoma have been identified in six loci, namely: c-myc, flvi-1, flvi-2, fit-1, pim-1 , and flit-1 [ 57 , 58 , 62 , 63 , 64 , 65 ].”
Section 2.1 identifies recurrent integration loci relevant to insertion-associated oncogenesis. This statement does not establish that every FeLV-associated lymphoma contains these integrations or that each integration is independently sufficient for malignant transformation.
Open questionConfidence 100/100
The potential protective role of enFeLV in oncogenesis remains incompletely understood.
Section 5 explicitly identifies this uncertainty. It does not establish that endogenous FeLV prevents lymphoma.
Open questionConfidence 100/100
The mechanisms by which FeLV LTRs influence mutagenesis remain incompletely understood.
Section 5 identifies unresolved mechanisms despite the integration-associated pathways discussed in Section 2.1. This uncertainty does not negate the review's conclusion that FeLV can directly induce neoplastic transformation.
Provenance
Source: Infectious Causes of Neoplasia in the Domestic Cat.
AVA